Europe Respiratory Inhalers Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product Type [Nebulizers, Metered Dose Inhalers (MDI), and Dry Powder Inhalers], Technology (Manually Operated Inhalers and Digitally Operated Inhalers), and Disease Indication (Asthma, COPD, Pulmonary Arterial Hypertension, and Others)  

No. of Pages: 162    |    Report Code: BMIRE00028391    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Respiratory Inhalers Market

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Europe Respiratory Inhalers Market – by Product Type

1.3.2        Europe Respiratory Inhalers Market – by Technology

1.3.3        Europe Respiratory Inhalers Market – by Disease Indication

1.3.4        Europe Respiratory Inhalers Market – by Country

2.           Europe Respiratory Inhalers Market – Key Takeaways

3.        Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Europe Respiratory Inhalers Market – Market Landscape

4.1         Overview

4.2         Europe PEST Analysis

4.3         Expert’s Opinion

5.           Europe Respiratory Inhalers Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Cases of Respiratory Disorders

5.1.2        Growing Adoption of Generic Inhalers

5.2         Market Restraints

5.2.1        Lack of Early Diagnosis and High Cost of Inhalers

5.3         Market Opportunities

5.3.1        Increasing Adoption of Smart Inhalers Technology

5.4         Future Trends

5.4.1        Increasing Product Development Activities

5.5         Impact Analysis

6.           Respiratory Inhalers Market – Europe Analysis

6.1         Europe Respiratory Inhalers Market Revenue Forecast and Analysis

7.           Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 – by Product Type

7.1         Overview

7.2         Europe Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)

7.3         Dry Powder Inhalers

7.3.1        Overview

7.3.2        Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.3.3        Multi-Dose Dry Powder Inhalers

7.3.3.1          Overview

7.3.3.2          Multi-Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.3.4        Single Dose Dry Powder Inhalers

7.3.4.1          Overview

7.3.4.2          Single Dose Dry Powder Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4         Metered Dose Inhalers

7.4.1        Overview

7.4.2        Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4.3        Pressured Metered Dose Inhalers

7.4.3.1          Overview

7.4.3.2          Pressured Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.4.4        Connected Metered Dose Inhalers

7.4.4.1          Overview

7.4.4.2          Connected Metered Dose Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5         Nebulizers

7.5.1        Overview

7.5.2        Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.3        Compressed Air Nebulizers

7.5.3.1          Overview

7.5.3.2          Compressed Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.4        Mesh Air Nebulizers

7.5.4.1          Overview

7.5.4.2          Mesh Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

7.5.5        Ultrasonic Air Nebulizers

7.5.5.1          Overview

7.5.5.2          Ultrasonic Air Nebulizers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

8.           Europe Respiratory Inhalers Market Analysis and Forecast to 2028 – by Technology

8.1         Overview

8.2         Europe Respiratory Inhalers Market, by Technology 2021 & 2028 (%)

8.3         Manually Operated Inhalers

8.3.1        Overview

8.3.2        Manually Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

8.4         Digitally Operated Inhalers

8.4.1        Overview

8.4.2        Digitally Operated Inhalers: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.           Europe Respiratory Inhalers Market Analysis and Forecast to 2028 – by Disease Indication

9.1         Overview

9.2         Europe Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)

9.3         Asthma

9.3.1        Overview

9.3.2        Asthma: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.4         COPD

9.4.1        Overview

9.4.2        COPD: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.5         Pulmonary Arterial Hypertension

9.5.1        Overview

9.5.2        Pulmonary Arterial Hypertension: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

9.6         Others

9.6.1        Overview

9.6.2        Others: Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

10.        Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 – Country Analysis

10.1      Overview

10.1.1     Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)

10.1.1.1       UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.1       Overview

10.1.1.1.2       UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.1.3       UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)

10.1.1.1.3.1     UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)

10.1.1.1.3.2     UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)

10.1.1.1.3.3     UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)

10.1.1.1.4       UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)

10.1.1.1.5       UK Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)

10.1.1.2       Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.1       Overview

10.1.1.2.2       Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.2.3       Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)

10.1.1.2.3.1     Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)

10.1.1.2.3.2     Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)

10.1.1.2.3.3     Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)

10.1.1.2.4       Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)

10.1.1.2.5       Germany Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)

10.1.1.3       France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.1       Overview

10.1.1.3.2       France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.3.3       France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)

10.1.1.3.3.1     France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)

10.1.1.3.3.2     France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)

10.1.1.3.3.3     France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)

10.1.1.3.4       France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)

10.1.1.3.5       France Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)

10.1.1.4       Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.1       Overview

10.1.1.4.2       Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.4.3       Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)

10.1.1.4.3.1     Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)

10.1.1.4.3.2     Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)

10.1.1.4.3.3     Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)

10.1.1.4.4       Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)

10.1.1.4.5       Italy Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)

10.1.1.5       Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.1       Overview

10.1.1.5.2       Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.5.3       Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)

10.1.1.5.3.1     Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)

10.1.1.5.3.2     Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)

10.1.1.5.3.3     Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)

10.1.1.5.4       Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)

10.1.1.5.5       Spain Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)

10.1.1.6       Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.1       Overview

10.1.1.6.2       Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

10.1.1.6.3       Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Product Type (US$ Mn)

10.1.1.6.3.1     Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Dry Powder Inhalers (US$ Mn)

10.1.1.6.3.2     Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Metered Dose Inhalers (US$ Mn)

10.1.1.6.3.3     Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Nebulizers (US$ Mn)

10.1.1.6.4       Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Technology (US$ Mn)

10.1.1.6.5       Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Disease Indication (US$ Mn)

11.        Industry Landscape

11.1      Overview

11.2      Inorganic Growth Strategies

11.2.1     Overview

11.3      Organic Growth Strategies

11.3.1     Overview

12.        Company Profiles

12.1      AstraZeneca Plc

12.1.1     Key Facts

12.1.2     Business Description

12.1.3     Products and Services

12.1.4     Financial Overview

12.1.5     SWOT Analysis

12.1.6     Key Developments

12.2      Beximco Pharmaceuticals Ltd.

12.2.1     Key Facts

12.2.2     Business Description

12.2.3     Products and Services

12.2.4     Financial Overview

12.2.5     SWOT Analysis

12.2.6     Key Developments

12.3      Boehringer Ingelheim International GmbH

12.3.1     Key Facts

12.3.2     Business Description

12.3.3     Products and Services

12.3.4     Financial Overview

12.3.5     SWOT Analysis

12.3.6     Key Developments

12.4      Cipla Ltd

12.4.1     Key Facts

12.4.2     Business Description

12.4.3     Products and Services

12.4.4     Financial Overview

12.4.5     SWOT Analysis

12.4.6     Key Developments

12.5      GSK Plc

12.5.1     Key Facts

12.5.2     Business Description

12.5.3     Products and Services

12.5.4     Financial Overview

12.5.5     SWOT Analysis

12.5.6     Key Developments

12.6      Koninklijke Philips NV

12.6.1     Key Facts

12.6.2     Business Description

12.6.3     Products and Services

12.6.4     Financial Overview

12.6.5     SWOT Analysis

12.6.6     Key Developments

12.7      OMRON Corp

12.7.1     Key Facts

12.7.2     Business Description

12.7.3     Products and Services

12.7.4     Financial Overview

12.7.5     SWOT Analysis

12.7.6     Key Developments

12.8      PARI Respiratory Equipment, Inc.

12.8.1     Key Facts

12.8.2     Business Description

12.8.3     Products and Services

12.8.4     Financial Overview

12.8.5     SWOT Analysis

12.8.6     Key Developments

12.9      Teva Pharmaceutical Industries Ltd

12.9.1     Key Facts

12.9.2     Business Description

12.9.3     Products and Services

12.9.4     Financial Overview

12.9.5     SWOT Analysis

12.9.6     Key Developments

12.10   OPKO Health, Inc

12.10.1  Key Facts

12.10.2  Business Description

12.10.3  Products and Services

12.10.4  Financial Overview

12.10.5  SWOT Analysis

12.10.6  Key Developments

13.        Appendix

13.1      About The Insight Partners

13.2      Glossary of Terms

 

 

LIST OF TABLES

Table 1.             UK Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 2.             UK Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 3.             UK Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 4.             UK Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 5.             UK Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 6.             UK Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 7.             Germany Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 8.             Germany Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 9.             Germany Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 10.          Germany Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 11.          Germany Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 12.          Germany Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 13.          France Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 14.          France Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 15.          France Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 16.          France Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 17.          France Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 18.          France Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 19.          Italy Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 20.          Italy Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 21.          Italy Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 22.          Italy Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 23.          Italy Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 24.          Italy Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 25.          Spain Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 26.          Spain Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 27.          Spain Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 28.          Spain Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 29.          Spain Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 30.          Spain Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 31.          Rest of Europe Respiratory Inhalers Market, by Product Type – Revenue and Forecast to 2028 (US$ Million)

Table 32.          Rest of Europe Respiratory Inhalers Market, by Dry Powder Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 33.          Rest of Europe Respiratory Inhalers Market, by Metered Dose Inhalers – Revenue and Forecast to 2028 (US$ Million)

Table 34.          Rest of Europe Respiratory Inhalers Market, by Nebulizers – Revenue and Forecast to 2028 (US$ Million)

Table 35.          Rest of Europe Respiratory Inhalers Market, by Technology – Revenue and Forecast to 2028 (US$ Million)

Table 36.          Rest of Europe Respiratory Inhalers Market, by Disease Indication – Revenue and Forecast to 2028 (US$ Million)

Table 37.          Recent Inorganic Growth Strategies

Table 38.          Recent Organic Growth Strategies

Table 39.          Glossary of Terms

 

 

LIST OF FIGURES

Figure 1.           Europe Respiratory Inhalers Market Segmentation

Figure 2.           Europe Respiratory Inhalers Market, by Country

Figure 3.           Europe Respiratory Inhalers Market Overview

Figure 4.           Europe Respiratory Inhalers Market, By Product

Figure 5.           Europe Respiratory Inhalers Market, By Country

Figure 6.           Europe: PEST Analysis

Figure 7.           Experts’ Opinion

Figure 8.           Europe Respiratory Inhalers Market: Impact Analysis of Drivers and Restraints

Figure 9.           Europe Respiratory Inhalers Market – Revenue Forecast and Analysis

Figure 10.        Europe Respiratory Inhalers Market Revenue Share, by Product, 2021 & 2028 (%)

Figure 11.        Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 12.        Multi-Dose Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 13.        Single Dose Dry Powder Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 14.        Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 15.        Pressured Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 16.        Connected Metered Dose Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 17.        Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 18.        Compressed Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 19.        Mesh Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 20.        Ultrasonic Air Nebulizers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 21.        Europe Respiratory Inhalers Market, by Technology 2021 & 2028 (%)

Figure 22.        Manually Operated Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 23.        Digitally Operated Inhalers: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 24.        Europe Respiratory Inhalers Market, by Disease Indication, 2021 & 2028 (%)

Figure 25.        Asthma: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 26.        COPD: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 27.        Pulmonary Arterial Hypertension: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 28.        Others: Europe Respiratory Inhalers Market – Revenue and Forecast to 2028 (US$ Million)

Figure 29.        Europe Respiratory Inhalers Market Revenue overview, by Country, 2021 (US$ MN)

Figure 30.        Europe Respiratory Inhalers Market Revenue and Forecasts to 2028, By Country (%)

Figure 31.        UK Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 32.        Germany Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 33.        France Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 34.        Italy Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 35.        Spain Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

Figure 36.        Rest of Europe Respiratory Inhalers Market Revenue and Forecasts to 2028 (US$ Mn)

 

The List of Companies - Europe Respiratory Inhalers Market

  1. AstraZeneca Plc
  2. Beximco Pharmaceuticals Ltd.
  3. Boehringer Ingelheim International GmbH
  4. Cipla Ltd
  5. GSK Plc 
  6. Koninklijke Philips NV
  7. OMRON Corp  
  8. OPKO Health, Inc
  9. PARI Respiratory Equipment, Inc.
  10. Teva Pharmaceutical Industries Ltd